Skip to content
Pygeum (Prunus africana)

Rosaceae · bark

Pygeum

Prunus africana

Human clinical trialsUse with caution

Bark extracts have older LUTS trials. Not first-line urologic care.

Safety first

Conservation and identity issues. Does not exclude cancer or retention. Wild bark harvest is a sustainability problem.

Tradition vs trials

Traditional record. African traditional bark later European extract for micturition complaints.

Trial literature. Older human LUTS files exist. Evidence is thinner and older than marketing.

Practical ranges

Educational ranges — not a prescription. Culinary use is not an extract.

  • bark extract

    Older trial extracts often about 100 mg/day of specified extract — educational, not a prescription

    ESCOP / WHO-monograph-era notesEducational range only — not a prescription. A licensed clinician individualizes product, dose, and duration.

Pregnancy, nursing, children

  • Pregnancy. Not relevant as a LUTS bark; avoid.
  • Nursing. Insufficient reliable data; avoid unless a clinician directs otherwise.
  • Children. Insufficient reliable data; avoid unless a clinician directs otherwise.

Contraindications

  • do not delay retention or cancer workup

Key interactions

  • none distinctive · note

    Urologic red flags dominate.

Open drug–herb checker

Used in these diagnoses